Neola Medical AB (NEOLA) - Total Assets
Based on the latest financial reports, Neola Medical AB (NEOLA) holds total assets worth Skr78.80 Million SEK (≈ $8.48 Million USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore Neola Medical AB cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Neola Medical AB - Total Assets Trend (2018–2025)
This chart illustrates how Neola Medical AB's total assets have evolved over time, based on quarterly financial data. See Neola Medical AB (NEOLA) shareholders funds for net asset value and shareholders' equity analysis.
Neola Medical AB - Asset Composition Analysis
Current Asset Composition (December 2025)
Neola Medical AB's total assets of Skr78.80 Million consist of 21.9% current assets and 78.1% non-current assets.
| Asset Category | Amount (SEK) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Skr0.00 | 20.5% |
| Accounts Receivable | Skr1.11 Million | 1.4% |
| Inventory | Skr0.00 | 0.0% |
| Property, Plant & Equipment | Skr0.00 | 0.0% |
| Intangible Assets | Skr0.00 | 0.0% |
| Goodwill | Skr0.00 | 0.0% |
Asset Composition Trend (2018–2025)
This chart illustrates how Neola Medical AB's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see NEOLA company net worth.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Neola Medical AB's current assets represent 21.9% of total assets in 2025, a decrease from 71.9% in 2018.
- Cash Position: Cash and equivalents constituted 20.5% of total assets in 2025, down from 70.4% in 2018.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2018.
- Asset Diversification: The largest asset category is accounts receivable at 1.4% of total assets.
Neola Medical AB Competitors by Total Assets
Key competitors of Neola Medical AB based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Cochlear Ltd
AU:COH
|
Australia | AU$2.83 Billion |
|
COCHLEAR LTD ADR 1/2/O.N.
F:OC50
|
Germany | €2.83 Billion |
|
Novocure Ltd
NASDAQ:NVCR
|
USA | $787.93 Million |
|
Sinocare Inc
SHE:300298
|
China | CN¥6.25 Billion |
|
L&C Bio Co. Ltd
KQ:290650
|
Korea | ₩497.94 Billion |
|
Shanghai ZJ Bio-Tech Co. Ltd. A
SHG:688317
|
China | CN¥3.71 Billion |
|
Bactiguard Holding AB (publ)
ST:BACTI-B
|
Sweden | Skr537.34 Million |
|
Sequana Medical NV
BR:SEQUA
|
Belgium | €14.57 Million |
Neola Medical AB - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 5.75 | 4.53 | 10.50 |
| Quick Ratio | 5.75 | 4.51 | 10.50 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | Skr14.24 Million | Skr16.39 Million | Skr30.87 Million |
Neola Medical AB - Advanced Valuation Insights
This section examines the relationship between Neola Medical AB's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.20 |
| Latest Market Cap to Assets Ratio | 0.06 |
| Asset Growth Rate (YoY) | 7.1% |
| Total Assets | Skr78.80 Million |
| Market Capitalization | $4.87 Million USD |
Valuation Analysis
Below Book Valuation: The market values Neola Medical AB's assets below their book value (0.06x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Neola Medical AB's assets grew by 7.1% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Neola Medical AB (2018–2025)
The table below shows the annual total assets of Neola Medical AB from 2018 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | Skr78.80 Million ≈ $8.48 Million |
+7.05% |
| 2024-12-31 | Skr73.61 Million ≈ $7.92 Million |
-14.42% |
| 2023-12-31 | Skr86.02 Million ≈ $9.26 Million |
+14.19% |
| 2022-12-31 | Skr75.33 Million ≈ $8.11 Million |
+71.88% |
| 2021-12-31 | Skr43.83 Million ≈ $4.72 Million |
+68.78% |
| 2020-12-31 | Skr25.97 Million ≈ $2.79 Million |
+112.41% |
| 2019-12-31 | Skr12.22 Million ≈ $1.32 Million |
-12.68% |
| 2018-12-31 | Skr14.00 Million ≈ $1.51 Million |
-- |
About Neola Medical AB
Neola Medical AB (publ), together with its subsidiary, Neola Medical, Inc., develops medical technology devices for non-invasive continuous monitoring of the lungs of preterm born infants in Sweden. It offers NEOLA, a neonatal intensive care medical device that enables continuous lung monitoring and real-time alerts of life-threatening complications using technology that measures lung volume chan… Read more